Clinical Trial Update: Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction [Phase 3]

View source ↗

Summary

Phase 3 trial update on dexamethasone regimens for prophylaxis of paclitaxel-associated hypersensitivity reaction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity Reaction

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Hypersensitivity Reaction | Phase 3 | Status: COMPLETED